MicroPort Endovascular completes second share repurchase for employee incentives

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. announced the completion of its second share repurchase, acquiring 1,333,943 shares, representing 1.08% of its total share capital. The repurchase was carried out via centralized bidding transactions, with prices ranging from RMB 84.26 to RMB 120 per share, at an average of RMB 105.03 per share. The total expenditure for this program amounted to RMB 140,098,144.06.

The repurchased shares are earmarked for employee stock ownership plans or equity incentive programs, with a commitment to utilize them within three years from the announcement date. The company confirmed that the repurchase met the approved board resolution, utilizing its own funds and specialized stock repurchase loans.

The repurchase scheme, initially disclosed on October 30, 2024, saw its price limit adjusted multiple times due to half-yearly and annual profit distribution plans. The company's equity structure remains stable post-repurchase, maintaining its listed status.